DiaMedica Therapeutics Provides a Business Update and Announces Fourth Quarter 2021 Financial Results
Conference Call and Webcast March 15 at 8:00 am Eastern Time / 7:00 am Central Time Currently Dosing Patients in Pivotal Phase 2/3 ReMEDy2 Acute Ischemic Stroke Trial Team Expanded with Addition... | March 14, 2022